Clinical trial
Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian…
NCT00003450 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00003450 |
|---|---|
| Title | Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer |
| Official title | Phase I Trial of Intraperitoneal Adenoviral p53 Gene Therapy in Patients With Advanced Recurrent or Persistent Ovarian Cancer |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Peritoneal Cavity Cancer |
| Intervention type | Biological |
| Interventions | Ad5CMV-p53 gene |
| Start date | Sep 1, 1998 |
| Primary completion | Jan 1, 1999 |
| Completion | Jan 1, 1999 |
| First posted | Dec 5, 2003 |
| Last update posted | Feb 2, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: